Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
about
Identification of functional domains on human interleukin 10Interleukin 1 receptor antagonist. A new member of the interleukin 1 familyCytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonistIntensive care.Anakinra treatment of patients with rheumatoid arthritis.Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.Microglia-derived IL-1β promotes chemokine expression by Müller cells and RPE in focal retinal degeneration.Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.Importance of interleukin-1 and interleukin-1 receptor antagonist in short-term glucose sensor function in vivo.Influence of interleukin-1 receptor antagonist gene polymorphism on disease.Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal ureaplasma urealyticum colonization in pregnant women.Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient miceThe molecular mechanisms of cervical ripening differ between term and preterm birthBovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea.Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor.Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptidesA bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.Human monocyte-derived macrophages infected with virulent Shigella flexneri in vitro undergo a rapid cytolytic event similar to oncosis but not apoptosisRole of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmiaRole of interleukin-1 in infectious diseases.Interleukin-1 receptor antagonist gene polymorphism in patients with multidrug-resistant Acinetobacter baumannii-associated pneumonia.Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A.Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.Interleukin 1: an important mediator of host resistance against Pneumocystis cariniiSerum corticosterone, interleukin-1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strainsInterleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo.Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.Gene expression pattern in human monocytes as a surrogate marker for systemic inflammatory response syndrome (SIRS)Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system.Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.Cytokine receptors of the lung.Cytokine networking of innate immunity cells: a potential target of therapy.Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family.Noncoding RNAs and chronic inflammation: Micro-managing the fire within.Effects of interleukin-1 receptor antagonist overexpression on infection by Listeria monocytogenes.Interleukin-1 receptor type I gene-deficient mice are less susceptible to Staphylococcus epidermidis biomaterial-associated infection than are wild-type mice.Interleukin-1 Gene Cluster Polymorphisms and its Haplotypes may Predict the Risk to Develop Cervical Cancer in Tunisia.Interleukin-4 inhibits secretion of interleukin-1beta in the response of human cells to mycobacterial heat shock proteins.
P2860
Q24315045-1DBAF64A-416F-493F-B453-437226C7218CQ24630432-BD3B8C9A-A086-43AF-95D5-6E4164053052Q28583823-B5696D70-6D3E-4D1E-B829-48795AF9680CQ30493400-287DF7FA-AF21-48DA-8C7C-DD8EEC64CFACQ31089069-F0AC3F28-4089-4DDD-9AA6-808D92569B07Q33211484-106E0D32-0FC0-4AF3-9E5A-69675384D094Q33602051-11729A23-5E52-4274-8D38-873525320EEAQ33971359-2FF262A1-C688-4F7D-A966-7420B6604C05Q34209078-E3296979-FC6D-4CAA-908A-B36532E9B370Q34461355-772C606F-0082-4B70-BA96-F57AFC99FFCEQ34531015-88FDFABF-9B8D-449D-90F9-87AE9B9F6E58Q34555906-8F24A4BA-8F55-4772-AB58-587A3BD27FD4Q34578522-692421C1-0626-4E7E-9810-371508CEBB9FQ34881192-216D31E7-AF72-4DDD-B94C-4FD622765DC4Q35117155-C784ED4A-8EA6-40B4-AACF-4DB4E77839DBQ35378360-01A90C7E-564D-4275-920E-DB153E3EDA9BQ35446580-1100E70B-AE3D-4CCC-9CBF-27BE1AA35282Q35545918-2A4200EB-32C4-4CE6-8E46-256FA4A3DEDDQ35619749-F1E8BF43-65EE-4E6B-A645-2305A3D364B0Q35732436-5BAAB2E8-EBED-414B-BF4B-F9DE19882DE9Q35919549-CBCAB69B-1AE2-483E-B989-CF1F809E65E2Q35936578-AD7FDCA9-9A55-43EB-80EE-ABA481C69ABDQ36029062-1417C2DA-A04A-4546-A575-40CE29520A29Q36231708-01D0AEBD-4D9F-4D57-A161-28C50149A956Q36330162-15FFE545-11B1-477F-944B-14433621E14DQ36361322-2F66B379-88FC-4F0E-8A66-7E3707B0CB7DQ36361487-F1B78038-477A-4175-BE23-ACB7FE885EF9Q36366486-F171A405-A6E0-48A5-9F1A-531283EAA34BQ36438188-7F772F30-D42C-4E97-B604-125132036E92Q36615163-63D9D4D0-9CD5-4875-A8D1-D0186F57B0F0Q36899057-3B693ADC-BD20-4FB7-BE1B-CBCFEBF412D4Q37376059-ACAE28D6-B6E8-4876-8F9C-94AD110437D0Q37421913-1A2B33C5-EF52-45D1-95AB-BF48D708A3B0Q38180799-DB51345A-3FDC-4001-848E-115A22CB2D45Q38293252-847E95B9-A9A0-42B5-BA1B-0F392B0A6241Q38561971-CC370983-A8A5-4622-9B45-721B376387F4Q39510548-40579F66-4FF0-4481-8B0C-B7F9B76B98AFQ39517362-9AA10F51-8A4B-4FB7-B423-1B8F81862ADDQ39631757-091FA0B7-AB48-41F7-AF09-D50C2C86A966Q39811703-94FD99D7-A64F-4A4A-AC3E-DAA112FF724F
P2860
Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Inhibition of interleukin 1 (I ...... receptor monoclonal antibody.
@ast
Inhibition of interleukin 1 (I ...... receptor monoclonal antibody.
@en
type
label
Inhibition of interleukin 1 (I ...... receptor monoclonal antibody.
@ast
Inhibition of interleukin 1 (I ...... receptor monoclonal antibody.
@en
prefLabel
Inhibition of interleukin 1 (I ...... receptor monoclonal antibody.
@ast
Inhibition of interleukin 1 (I ...... receptor monoclonal antibody.
@en
P2093
P2860
P356
P1476
Inhibition of interleukin 1 (I ...... receptor monoclonal antibody.
@en
P2093
Benjamin WR
Chizzonite RA
Kolinsky KD
McIntyre KW
Plocinski JM
P2860
P304
P356
10.1084/JEM.173.4.931
P407
P577
1991-04-01T00:00:00Z